Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Quality Compounders to Own for Decades

By: StockStory

March 16, 2026 at 00:37 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

VRT Cover Image

Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more profits. Rinse and repeat.

We love companies like this because something about their business models makes them special. That said, here are three quality compounders that could amplify your portfolio’s returns.

Vertiv (VRT)

Market Cap: $99.05 billion

Formerly part of Emerson Electric, Vertiv (NYSE: VRT) manufactures and services infrastructure technology products for data centers and communication networks.

Why Do We Love VRT?

Average organic revenue growth of 21.9% over the past two years demonstrates its ability to expand independently without relying on acquisitions
Free cash flow margin jumped by 16 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
Rising returns on capital show management is finding more attractive investment opportunities

Vertiv is trading at $258.29 per share, or 43.2x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

Trane Technologies (TT)

Market Cap: $93.49 billion

With low-pressure heating systems as its first product, Trane (NYSE: TT) designs, manufactures, and sells HVAC and refrigeration systems, the former to commercial and residential building customers and the latter to commercial truck manufacturers.

Why Will TT Beat the Market?

Impressive 11.4% annual revenue growth over the last five years indicates it’s winning market share this cycle
Share buybacks catapulted its annual earnings per share growth to 20.2%, which outperformed its revenue gains over the last two years
Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures, and its rising returns show it’s making even more lucrative bets

Trane Technologies’s stock price of $422.41 implies a valuation ratio of 28.5x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.

Eli Lilly (LLY)

Market Cap: $880 billion

Founded in 1876 by a Civil War veteran and pharmacist frustrated with the poor quality of medicines, Eli Lilly (NYSE: LLY) discovers, develops, and manufactures pharmaceutical products for conditions including diabetes, obesity, cancer, immunological disorders, and neurological diseases.

Why Are We Backing LLY?

Annual revenue growth of 38.2% over the past two years was outstanding, reflecting market share gains this cycle
Adjusted operating margin expanded by 21.2 percentage points over the last two years as it scaled and became more efficient
Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue

At $983.75 per share, Eli Lilly trades at 28.2x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	264.14	-3.08 (-1.15%)
AAPL	300.23	+2.02 (0.68%)
AMD	424.10	-25.60 (-5.69%)
BAC	49.77	-0.08 (-0.16%)
GOOG	393.32	-3.85 (-0.97%)
META	614.23	-4.20 (-0.68%)
MSFT	421.92	+12.49 (3.05%)
NVDA	225.32	-10.42 (-4.42%)
ORCL	192.95	-2.66 (-1.36%)
TSLA	422.24	-21.06 (-4.75%)